Ambuja Cements (AMBUJACEM) — Financial Results

Ambuja Cements reported a 69.9% YoY revenue increase to ₹87.22 crores for the quarter ended March 2025, driven by strong demand in the construction sector. The filing notes no material changes from the prior period beyond this growth, and no forward guidance was provided. The company announced a temporary trading window closure for insider transactions ahead of audited results.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this financial results affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 29 March 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 29 March 2025

COALINDIA Coal India Limited Insider Trading POLYCAB Polycab India Limited Financial Results POWERGRID Power Grid Corporation of India Limited Financial Results SBICARD SBI Cards and Payment Services Limited Board Meeting BAJAJ-AUTO Bajaj Auto Limited Voting Results BPCL Bharat Petroleum Corporation Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.